RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 96 filers reported holding RELMADA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $549,830 | +1310.0% | 118,243 | +809.7% | 0.00% | – |
| Q3 2023 | $38,994 | -90.2% | 12,998 | -92.0% | 0.00% | – |
| Q2 2023 | $399,374 | -11.6% | 162,347 | -18.8% | 0.00% | – |
| Q1 2023 | $451,602 | -50.6% | 199,824 | -23.6% | 0.00% | – |
| Q4 2022 | $913,365 | +34484.1% | 261,709 | +266.8% | 0.00% | -100.0% |
| Q3 2022 | $2,641 | -24.5% | 71,347 | -61.3% | 0.00% | 0.0% |
| Q2 2022 | $3,498 | -99.6% | 184,174 | +528.8% | 0.00% | – |
| Q1 2022 | $791,000 | -58.3% | 29,291 | -65.2% | 0.00% | – |
| Q4 2021 | $1,899,000 | -15.9% | 84,288 | -2.1% | 0.00% | – |
| Q3 2021 | $2,257,000 | +252.1% | 86,082 | +329.4% | 0.00% | – |
| Q2 2021 | $641,000 | -21.8% | 20,045 | -13.9% | 0.00% | – |
| Q1 2021 | $820,000 | +81.4% | 23,284 | +65.3% | 0.00% | – |
| Q4 2020 | $452,000 | -87.5% | 14,085 | -86.7% | 0.00% | -100.0% |
| Q1 2020 | $3,624,000 | +1617.5% | 106,245 | +1862.8% | 0.00% | – |
| Q4 2019 | $211,000 | – | 5,413 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 2,837,818 | $9,903,985 | 0.42% |
| Sio Capital Management, LLC | 235,500 | $821,895 | 0.30% |
| Sio Capital Management, LLC | 235,600 | $822,244 | 0.30% |
| apricus wealth, LLC | 77,329 | $269,878 | 0.25% |
| RTW INVESTMENTS, LP | 2,067,824 | $7,216,706 | 0.15% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 496,254 | $1,731,926 | 0.14% |
| Aristides Capital LLC | 69,322 | $241,934 | 0.12% |
| XTX Topco Ltd | 129,387 | $451,561 | 0.10% |
| AdvisorShares Investments LLC | 81,362 | $283,953 | 0.08% |
| Ikarian Capital, LLC | 65,491 | $228,563 | 0.06% |